Edgewood Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Edgewood Management's BMY Position: Q2 2026 in Review
Edgewood Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 21,522 shares worth $1.24M. The position accounts for 0.01% of the portfolio, ranked #63.
Edgewood Management first reported a position in BMY in Q4 2019 and has held it in 27 quarters since. The position peaked at $6M in Q2 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Edgewood Management held 21,522 shares of Bristol-Myers Squibb worth $1.24M as of Q2 2026.
- Edgewood Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.01% of Edgewood Management's portfolio in Q2 2026, its #63 holding.
- Edgewood Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 27 quarters since.
- Edgewood Management's Bristol-Myers Squibb position peaked at $6M in Q2 2022.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Edgewood Management's 13F filing for Q2 2026, filed 13 Aug 2026.